Close linkage between blood total ketone body levels and B-type natriuretic peptide levels in patients with cardiovascular disorders

Close linkage between blood total ketone body levels and B-type natriuretic peptide levels in patients with cardiovascular disorders

Abstract In patients with cardiovascular disorders, blood total ketone body (TKB) levels increase with worsening heart failure and are consumed as an alternative fuel to fatty acid and glucose. We investigated factors contributing to the increase in the blood TKB levels in patients with cardiovascul...

Full description

Bibliographic Details
Main Authors:	Yusuke Kashiwagi, Tomohisa Nagoshi, Yasunori Inoue, Yoshiro Tanaka, Hirotake Takahashi, Yuhei Oi, Haruka Kimura, Kousuke Minai, Michihiro Yoshimura
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-03-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-86126-0

Similar Items

Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure
by: Hirotake Takahashi, et al.
Published: (2021-11-01)

Treatment with atrial natriuretic peptide induces adipose tissue browning and exerts thermogenic actions in vivo
by: Haruka Kimura, et al.
Published: (2021-08-01)

Substantial impact of 3-iodothyronamine (T1AM) on the regulations of fluorescent thermoprobe-measured cellular temperature and natriuretic peptide expression in cardiomyocytes
by: Hirotake Takahashi, et al.
Published: (2022-07-01)

Effects of angiotensin receptor‐neprilysin inhibitor on insulin resistance in patients with heart failure
by: Yusuke Kashiwagi, et al.
Published: (2023-06-01)

Exogenous ANP Treatment Ameliorates Myocardial Insulin Resistance and Protects against Ischemia–Reperfusion Injury in Diet-Induced Obesity
by: Yuhei Oi, et al.
Published: (2022-07-01)

URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease
by: Yoshiro Tanaka, et al.
Published: (2023-09-01)

Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis
by: Yoshiro Tanaka, et al.
Published: (2017-05-01)

Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
by: Akira Yoshii, et al.
Published: (2019-07-01)

Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor.
by: Joshi Tsutsumi, et al.
Published: (2017-01-01)

The plasma B-type natriuretic peptide levels are low in males with stable ischemic heart disease (IHD) compared to those observed in patients with non-IHD: a retrospective study.
by: Kosuke Minai, et al.
Published: (2014-01-01)

Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis.
by: Satoshi Ito, et al.
Published: (2017-01-01)

Possible diverse contribution of coronary risk factors to left ventricular systolic and diastolic cavity sizes
by: Kenichiro Suzuki, et al.
Published: (2021-01-01)

Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: Paradoxical contribution of plasma glucose level and glycohemoglobin
by: Sekiyama Hiroshi, et al.
Published: (2013-01-01)

Relationship between haemodynamic indicators and haemogram in patients with heart failure
by: Takuya Oh, et al.
Published: (2023-04-01)

Parallel comparison of risk factors between progression of organic stenosis in the coronary arteries and onset of acute coronary syndrome by covariance structure analysis.
by: Kazuo Ogawa, et al.
Published: (2017-01-01)

Caveats in the interpretation of natriuretic peptide levels
by: Chia-Ter Chao
Published: (2011-01-01)

Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice.
by: Yusuke Kashiwagi, et al.
Published: (2015-01-01)

Serum B-type natriuretic peptide level and timing of its measurement as a predictor of acute ischemic stroke outcome
by: Kousuke Fukuhara, et al.
Published: (2020-03-01)

The role of Na<sup>+</sup>/H<sup>+ </sup>exchanger in Ca<sup>2+ </sup>overload and ischemic myocardial damage in hearts from type 2 diabetic <it>db/db </it>mice
by: Anzawa Ryuko, et al.
Published: (2012-04-01)

Effect of fixed-dose losartan/hydrochlorothiazide on brain natriuretic peptide in patients with hypertension
by: Yuhei Shiga, et al.
Published: (2012-03-01)

Value of the natriuretic peptide level in diagnostics of newborns with heart failure
by: I. N. Maslennikova, et al.
Published: (2019-06-01)

Acute effects of insulin on circulating natriuretic peptide levels in humans.
by: Katherine N Bachmann, et al.
Published: (2018-01-01)

Plasma brain natriuretic peptide levels are elevated in patients with cancer.
by: Sachiko Bando, et al.
Published: (2017-01-01)

Evaluation of Serum Levels of N-terminal Pro Brain Natriuretic Peptide and Atrial Natriuretic Peptide in Neonates with Respiratory Distress
by: Noor Mohammad Noori, et al.
Published: (2016-06-01)

PO-04 CORRELATIONS BETWEEN ARTERIAL STIFFNESS/CENTRAL HEMODYNAMICS AND SERUM CARDIAC TROPONIN T AND NATRIURETIC PEPTIDE LEVELS
by: Hirofumi Tomiyama, et al.
Published: (2014-11-01)

Plasma Levels of Brain Natriuretic Peptides and Cardiac Troponin in Hemodialysis Patients
by: Halima Resić, et al.
Published: (2009-05-01)

Β-Natriuretic Peptide Level as a Predictor for the Severity of LV Dysfunction
by: Tharwet H. Nasser, et al.
Published: (2008-01-01)

Plasma brain natriuretic peptide levels in COPD without pulmonary hypertension
by: Ahmed G. El Gazzar, et al.
Published: (2017-01-01)

B-natriuretic peptide serum levels in neonates with persistent pulmonary hypertension
by: Tamer A. Abdel Hamid, et al.
Published: (2021-04-01)

Factors associated with increased levels of brain natriuretic peptide and cardiac troponin I during the peripartum period.
by: Yuki Kimura, et al.
Published: (2019-01-01)

PLASMA-LEVELS OF ATRIAL NATRIURETIC PEPTIDE (ANP) IN OBSTRUCTIVE SLEEP-APNEA (OSA)
by: Warley, A, et al.
Published: (1988)

Lack of effect of an inspiratory threshold load on plasma atrial natriuretic peptide levels.
by: Warley, A, et al.
Published: (1990)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Assessment of Atrial Natriuretic Peptide (ANP) Level and Relationship with Some Physiological Parameters
by: Wala'a Hassan Hadi, et al.
Published: (2021-05-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome
by: Swiss Medical Weekly
Published: (2003-09-01)

Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
by: Deepak K. Gupta, et al.
Published: (2015-05-01)

Racial/ethnic differences in circulating natriuretic peptide levels: The Diabetes Prevention Program.
by: Deepak K Gupta, et al.
Published: (2020-01-01)

B-type natriuretic peptide levels and diagnostic accuracy: excess fluid volume
by: Melina Maria Trojahn, et al.
Published: (2020-04-01)

Levels of Circulating Ketone Bodies in Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass
by: Anja Levis, et al.
Published: (2024-02-01)